ADO

0.00%

2.2¢ anteotech ltd

Ann: Therapeutic Goods Administration Registration Submitted, page-289

First 289 Last

Share
Profile

Follow
peak2peak

3,133 Posts.

348

18/11/21

08:15

Post #: 57658957
Share

Originally posted by opel24v: ↑

What you say is very true. DX companies have very long lead times as us long-termers know and we have been patient but...

Last year we were given a very clear roadmap.

Product launch was meant to have been done after getting TGA/CE/FDA approval, after all you can't sell a test until you have approval.

Good plan.

However, TGA and FDA were dropped in order to concentrate on the huge market in Europe. Fair enough. We were happy with this plan as we could come back to TGA/FDA approvals at a later date. Unknown to us, they had no sales pipeline lined up in Europe. The Israel trials sounded very promising. After all, it was the Israeli government that approached us. Surely, we'd get some sales from them as they were struggling with Covid. We had other promising leads as well but like all things ADO, when it comes time to commercialize, we fail miserably. Look at what's going on with Ellume, they can't even get that deal closed, and that's with a "friend".

When EuGeni was launched I expected to hear of at least one sales contract. In the 7 months since launch what have we sold?

On this one, the B/W's can whinge all they want because clearly ADO's commercialization strategy was flawed

Thank god we have the Abbott guy starting soon. If changes haven't already been made, he'll make them

Expand

we should wait till the TGA approval before firing the barbs. I am expecting sales ANNs to accompany or follow.
Posters are criticizing managements plan to go to Europe before getting their own house in order. I think the Italian
venture is going to prove 'how right they are'
why do you and others go on about sales figures when ...legally we are not able to sell till TGA approval.

it amazes me why many harp on about SALES when we are not allowed to.

ADO Price at posting: 21.0¢ Sentiment: Buy Disclosure: Held
7 Upvote

1 Great analysis

Reply

Top Stories

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

HLX

Helix investor makes partial takeover bid, proposing board changes

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

There are more pages in this discussion • 361 more messages in this thread...

First 289 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.2¢		Change 0.000(0.00%)		Mkt cap ! $54.31M

Open	High	Low	Value	Volume
2.2¢	2.2¢	2.2¢	$15.57K	707.7K

Buyers (Bids)

No.	Vol.	Price($)
1	89645	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.2¢	385723	1

View Market Depth

No.	Vol.	Price($)
1	89645	0.021
12	2026809	0.020
8	1197237	0.019
10	2275012	0.018
7	1012891	0.017

Price($)	Vol.	No.
0.022	385723	1
0.023	541962	4
0.024	154809	3
0.025	384791	4
0.026	158542	1

Last trade - 16.10pm 30/08/2024 (20 minute delay)

ADO (ASX) Chart

Ann: Therapeutic Goods Administration Registration Submitted, page-289

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Helix investor makes partial takeover bid, proposing board changes

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Lendlease sells off US east coast construction operations in latest global divestment push

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Therapeutic Goods Administration Registration Submitted, page-289

Top Stories

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Helix investor makes partial takeover bid, proposing board changes

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

Lendlease sells off US east coast construction operations in latest global divestment push

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News